Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Heron Therapeutics Inc (HRTX)  
$2.74 0.00 (0.00%) as of 4:30 Tue 3/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 118,760,000
Market Cap: 325.40(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.54 - $3.06
Level I Sector: Basic Materials
Level II Sector: Chemicals
Level III Sector: Synthetics

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  670
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Heron Therapeutics is a commercial-stage biotechnology company focused on developing treatments for acute care and oncology patients. Co.'s main product, SUSTOL is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide combination chemotherapy regimens. Co.'s other products include: CINVANTI, which is indicated in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy; and ZYNRELEF, which is indicated in adults for soft tissue or periarticular instillation.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 310,000 2,796,744 2,796,744
Total Buy Value $0 $287,814 $3,694,653 $3,694,653
Total People Bought 0 3 4 4
Total Buy Transactions 0 4 5 5
Total Shares Sold 0 0 0 1,504
Total Sell Value $0 $0 $0 $7,154
Total People Sold 0 0 0 1
Total Sell Transactions 0 0 0 1
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 497
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Dissanaike Sharmila Director   –       •      –    2024-01-19 4 A $0.00 $0 D/D 13,948 69,230     -
   Rodriguez Susan Director   –       •      –    2024-01-19 4 A $0.00 $0 D/D 13,948 69,230     -
   Christian Waage Director   –       •      –    2024-01-19 4 A $0.00 $0 D/D 13,948 66,180     -
   Johnson Craig A Director   –       •      –    2024-01-19 4 A $0.00 $0 D/D 13,948 65,820     -
   Morgan Adam Director   –       •      –    2024-01-19 4 A $0.00 $0 D/D 13,948 51,827     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2024-01-13 4 D $2.15 $1,625 D/D (756) 55,907     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2024-01-13 4 OE $0.00 $0 D/D 1,841 56,663     -
   Forbes William P EVP, Chief Development Officer   •       –      –    2023-11-17 4 B $1.09 $27,250 D/D 25,000 79,000 2.74 151%     
   Forbes William P EVP, Chief Development Officer   •       –      –    2023-11-16 4 B $0.94 $46,995 D/D 50,000 54,000 2.74 199%     
   Collard Craig A Chief Executive Officer   •       •      –    2023-11-16 4 B $0.92 $137,970 D/D 150,000 186,496 2.81 199%     
   Duarte Ira EVP, Chief Financial Officer   •       –      –    2023-11-16 4 B $0.89 $75,599 D/D 85,000 85,000 2.74 199%     
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-10-13 4 D $0.72 $619 D/D (860) 54,822     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-10-13 4 OE $0.00 $0 D/D 2,484 55,682     -
   Collard Craig A Chief Executive Officer   •       •      –    2023-08-22 4 D $1.65 $1,142 D/D (692) 36,496     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-07-25 4 D $1.51 $22,262 D/D (14,743) 53,198     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-07-25 4 OE $0.00 $0 D/D 42,631 67,941     -
   Rosen David Efraim 10% Owner   –       –       •   2023-07-21 3 IO $0.00 $0 I/I 0 26,713,503 -12%     
   Morgan Adam Director   –       •      –    2023-07-21 4 B $1.37 $3,406,839 I/I 2,486,744 6,986,744 2.1 -12%     
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-07-13 4 D $1.31 $1,127 D/D (860) 25,310     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-07-13 4 OE $0.00 $0 D/D 2,485 26,170     -
   Szekeres David Leslie EVP, Chief Operating Officer   •       –      –    2023-07-13 4 D $1.31 $2,636 D/D (2,012) 33,754     -
   Szekeres David Leslie EVP, Chief Operating Officer   •       –      –    2023-07-13 4 OE $0.00 $0 D/D 5,814 35,766     -
   Forbes William P EVP, Chief Development Officer   •       –      –    2023-06-06 3 IO $0.00 $0 D/D 0 4,000 -35%     
   Collard Craig A Chief Executive Officer   •       •      –    2023-05-22 4 D $1.45 $1,002 D/D (691) 37,188     -
   Peraza Lisa VP, Chief Accounting Officer   •       –      –    2023-04-13 4 D $2.88 $2,477 D/D (860) 23,685     -

  497 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed